CommentarySimplified vs complex adjuvant chemotherapy schedule for osteosarcoma
References (1)
- et al.
Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy
Cancer
(1982)
Cited by (12)
Multifunctional microcapsules: A theranostic agent for US/MR/PAT multi-modality imaging and synergistic chemo-photothermal osteosarcoma therapy
2022, Bioactive MaterialsCitation Excerpt :Osteosarcoma is an aggressive malignant neoplasm that arises from primitive transformed cells of mesenchymal origin and triggers osteoblastic differentiation and malignant osteoid [1,2]. In general, therapeutic strategies comprise the aggressive multimodal therapy including preoperative (neoadjuvant) chemotherapy followed by surgical removal of all detectable disease, and postoperative (adjuvant) chemotherapy [3–5]. Currently, most active chemotherapeutic agents for osteosarcoma are a combination of high-dose methotrexate, doxorubicin, and cisplatin with the use of IFN-α or the recent immunomodulatory mifamurtide during adjuvant chemotherapy [6,7].
Carbon dot/WS<inf>2</inf> heterojunctions for NIR-II enhanced photothermal therapy of osteosarcoma and bone regeneration
2020, Chemical Engineering JournalCitation Excerpt :Osteosarcoma is an aggressive malignant neoplasm that is most prevalent in teenagers and young adults [1,2]. In the clinic, surgical resection is commonly used to treat osteosarcoma [3–5]. However, incomplete bone-tumor cell elimination and the formation of bone defects seriously hinder the clinic application of surgical intervention [6,7].
Triazine-modified dendrimer for efficient TRAIL gene therapy in osteosarcoma
2015, Acta BiomaterialiaCitation Excerpt :Osteosarcoma is the most common type of primary bone tumors and the second high cause of cancer-related deaths in children and young adults [1].
W-Doped TiO<inf>2</inf>Nanorods for Multimode Tumor Eradication in Osteosarcoma Models under Single Ultrasound Irradiation
2021, ACS Applied Materials and Interfaces